Publication date: Jul 01, 2024
Whole-Body Vibration (WBV) can be a therapeutic recovery strategy for patients hospitalized for COVID-19. To evaluate the effects of a 36-session WBV protocol on the risk of falls, balance, mobility and heart rate variability (HRV). A randomized clinical trial. 13 patients affected by COVID-19, trained with WBV, 3cD7/week on alternate days, totaling 36 sessions, were evaluated before and after the intervention. WBV training at 2 mm and 4 mm amplitude resulted in a reduction in the risk of falls when compared to Sham (p = 0. 023), with effect size of 0. 530. No changes were observed for mobility and balance outcomes (p = 0. 127) or for any of the HRV variables (p = 0. 386). WBV training reduced the risk of falls in post-COVID patients. No changes were observed regarding balance and mobility, nor for HRV.
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | COVID-19 |
| disease | VO | protocol |
| disease | IDO | intervention |
| disease | MESH | Autonomic nervous system diseases |
| disease | MESH | Lung diseases |